Market Overview

UPDATE: Piper Jaffray Reduces PT to $8 on Molycorp on Liquidity and Regulatory Concerns

Related MCP
Must Watch Stocks for March 16, 2015
Earnings Scheduled For March 16, 2015
CBS 60 Minutes Highlight Put Rare Earth ETF in Focus - ETF News And Commentary (Zacks)

Piper Jaffray reiterated its Neutral rating on Molycorp (NYSE: MCP) but reduced its price target from $13 to $8.

Piper Jaffray commented, "We remain skeptical on MCP's output at Mountain Pass and have slashed our CY13 estimates again to 8,000MT (previously 14,250MT). With $436m in cash on hand and capex outlay of $475m over the next 3 quarters, we remain concerned about Molycorp's liquidity needs. Finally, the company has been subjected to a inquiry by SEC regarding its public disclosures and consistency. We are reducing our PT to $8 based on 1x CY13 sales of $975m. Reiterate Neutral with a negative bias."

Molycorp closed at $7.50 on Friday.

Latest Ratings for MCP

Jan 2015DA DavidsonDowngradesBuyNeutral
Aug 2014Euro PacificDowngradesHoldSell
Aug 2014Euro PacificUpgradesSellHold

View More Analyst Ratings for MCP
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Price Target Intraday Update Analyst Ratings


Related Articles (MCP)

Around the Web, We're Loving...